Answer
Campto (irinotecan) is indicated to treat advanced colorectal cancer (cancer of the colon or rectum), including metastatic disease.
Sources for this answer
- Campto 20mg/ml concentrate for solution for infusion (40mg presentation)Pfizer Limited · emc · SmPC §4.1 Therapeutic Indications · Version 27Document updated
Sources checked